Vaccination against HPV-16 oncoproteins for vulvar intraepithelial neoplasia. - Wikidata - awgldk - TriplyDB

Vaccination against HPV-16 oncoproteins for vulvar intraepithelial neoplasia.

Vaccination against HPV-16 oncoproteins for vulvar intraepithelial neoplasia.

http://www.wikidata.org/entity/Q39296306

about

A Chlamydomonas-derived Human Papillomavirus 16 E7 vaccine induces specific tumor protection Role of human papillomaviruses in carcinogenesis Medical and surgical interventions for the treatment of usual-type vulval intraepithelial neoplasia Medical interventions for high-grade vulval intraepithelial neoplasia Medical and surgical interventions for the treatment of usual-type vulval intraepithelial neoplasia The tumorigenic liver fluke Opisthorchis viverrini--multiple pathways to cancer The forgotten woman's cancer: vulvar squamous cell carcinoma (VSCC) and a targeted approach to therapy The promise of immunotherapy in head and neck squamous cell carcinoma Chimeric antigen receptor T-cell therapy for solid tumors Novel cancer antigens for personalized immunotherapies: latest evidence and clinical potential Clinical significance of human papillomavirus genotyping Interest of Tumor-Specific CD4 T Helper 1 Cells for Therapeutic Anticancer Vaccine Whole Tumor Antigen Vaccines: Where Are We?Immune Reactivation by Cell-Free Fetal DNA in Healthy Pregnancies Re-Purposed to Target Tumors: Novel Checkpoint Inhibition in Cancer Therapeutics Vaccines, Adjuvants, and Dendritic Cell Activators--Current Status and Future Challenges.VIN usual type-from the past to the future Therapy of human papillomavirus-related disease An updated overview of HPV-associated head and neck carcinomas Translation of genomics-guided RNA-based personalised cancer vaccines: towards the bedside Cancer vaccines Innate immune recognition of HIV-1 In vivo imaging of therapy-induced anti-cancer immune responses in humans.Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy Perspectives for therapeutic HPV vaccine development Novel Immunotherapeutic Approaches for Head and Neck Squamous Cell Carcinoma Adjuvants for peptide-based cancer vaccines Monitoring of the Immune Dysfunction in Cancer Patients Validation of biomarkers to predict response to immunotherapy in cancer: Volume I - pre-analytical and analytical validation Major clinical research advances in gynecologic cancer in 2015 Cross-Reactivity, Epitope Spreading, and De Novo Immune Stimulation Are Possible Mechanisms of Cross-Protection of Nonvaccine Human Papillomavirus (HPV) Types in Recipients of HPV Therapeutic Vaccines Current status of human papillomavirus vaccines Chemical Modification of Influenza CD8+ T-Cell Epitopes Enhances Their Immunogenicity Regardless of Immunodominance Recommendations from the iSBTc-SITC/FDA/NCI Workshop on Immunotherapy Biomarkers.Cancer immunotherapy comes of age Management of Oropharyngeal Cancer in the HPV Era.Synthetic Long Peptide Influenza Vaccine Containing Conserved T and B Cell Epitopes Reduces Viral Load in Lungs of Mice and Ferrets.Enhanced cancer radiotherapy through immunosuppressive stromal cell destruction in tumors Pre-immature dendritic cells (PIDC) pulsed with HPV16 E6 or E7 peptide are capable of eliciting specific immune response in patients with advanced cervical cancer.The present and future of peptide vaccines for cancer: single or multiple, long or short, alone or in combination?Minimal information about T cell assays: the process of reaching the community of T cell immunologists in cancer and beyond.

P2860

Q21133563-0420174F-02C1-4E89-90FF-1E247E6659C4 Q22305628-B8BCC3FF-09DC-4DA0-9026-F6FC5E5AD542 Q24186582-0660FEE8-E5FB-41C8-8601-D137170E060D Q24187846-EEB98058-B18C-45A4-8509-CD339738BC99 Q24188112-0013B30A-D68C-4014-B8C6-669B4F6D1604 Q24612587-112DF199-1265-4D41-9D2A-64936FCBAEB4 Q26744087-DF7DEAE4-5C26-4891-BFE6-ACC650300E4C Q26744433-390C11DB-6AC3-4404-9BE6-70D5073185B8 Q26750908-F6780EA6-7A88-430C-904A-4F02DDEFC65D Q26769884-CB29D7B8-E690-4583-B489-05C3FE4A8496 Q26771981-E06262C5-ACDF-4335-BD6B-98536550580B Q26782583-7101FF9C-73B5-4F16-9139-95E239A0C281 Q26783866-4931A5C0-7B40-418A-BABC-408F920AC7BA Q26784480-A4484095-9E37-4941-9ECC-A67E422B00F0 Q26796314-A7C02251-9217-41F5-A3C5-B962D6CA9352 Q26865303-9438B526-D84A-457D-BB20-6B329394A79B Q27007473-D277F886-7B8F-48B3-850C-1CC5B03BB448 Q27014019-153E31D7-96EC-4379-B700-F60E80645B6E Q27015695-A39DF0F7-6B5E-44F8-AAB1-C0A97E91FEF8 Q27024438-65EA0DA5-321F-4A9E-B036-6F849A0F0B17 Q27025598-3F1B6555-9F6F-4FCB-9363-3D10D6FB4CF3 Q27693338-B331818C-BD87-4866-9655-DBB16ECC041D Q28005535-16DB5873-C25D-46E0-84C8-F00D95FDEAD4 Q28069272-AEA0C32A-B51F-45F1-937F-2BE966759867 Q28071998-D0BE4A48-3B63-4CF5-AA8E-891E3E69DF9B Q28072236-65582D51-428D-4234-95B4-6AD6BB85619D Q28072712-57C0F11D-8D62-47C9-9187-4BEAB7B3D9B3 Q28075719-9D6F2A18-8AD9-420E-80AB-E476367DFFD9 Q28077183-62E685BD-40D7-4634-9CAA-5346D6F78C1B Q28085724-DDB80342-1ED0-41CC-AA5B-A2DAA4B9623E Q28289555-CA98D63E-24E1-45EA-A7C7-AA2B49761FC5 Q28552025-28D95343-DAB7-42C9-9ACA-ED872B6C4494 Q28744503-EF1EF2B2-75AD-45D9-A21A-8AAB1D8E0C30 Q29619918-158D3EE1-4378-4267-8804-4187DFE091C3 Q30248326-020A72C4-516F-49F2-912F-3248992B008A Q30375348-61E2D2B0-AD0E-4006-908C-A74575BBB318 Q30408302-80210016-BE60-4DEF-A0AF-B498DF9FBFE4 Q30409053-E29013E4-8026-414B-9521-BCD1799ED607 Q30425111-F5AB7B02-0ECD-4D3C-9AD8-73F1D4EE82F9 Q30432926-D3F41F89-EA27-4A5A-A210-98C2258FCE3A

P2860

Vaccination against HPV-16 oncoproteins for vulvar intraepithelial neoplasia.

http://www.wikidata.org/entity/Q39296306

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

2009年论文

@zh

2009年论文

@zh-cn

name

Vaccination against HPV-16 oncoproteins for vulvar intraepithelial neoplasia.

@en

Vaccination against HPV-16 oncoproteins for vulvar intraepithelial neoplasia.

@nl

type

label

Vaccination against HPV-16 oncoproteins for vulvar intraepithelial neoplasia.

@en

Vaccination against HPV-16 oncoproteins for vulvar intraepithelial neoplasia.

@nl

prefLabel

Vaccination against HPV-16 oncoproteins for vulvar intraepithelial neoplasia.

@en

Vaccination against HPV-16 oncoproteins for vulvar intraepithelial neoplasia.

@nl

P1433

Q39296306-6EA09391-D214-40E5-B5A9-7E2678BB1477

P1476

Q39296306-EE151524-76B5-47EE-90AA-221FFDAAB017

P2093

Q39296306-10BE4EDD-A7F6-42EE-89BD-4F7642571FF3

Q39296306-1FACA110-07EB-4BCC-81ED-AC4377EC5FFF

Q39296306-24EE6890-D665-415A-849F-FF448A7FB460

Q39296306-2E618381-7E83-47FF-8D1B-ABAAFBA3E756

Q39296306-34D8D614-BE26-4C0C-B81E-33230D6C10E7

Q39296306-3B17048D-6072-4087-98F8-0E5380CA5923

Q39296306-552C99D7-154B-4B2F-854B-87C45D6692D3

Q39296306-6571D423-7772-47A1-93A2-655632C598F6

Q39296306-6ECD6AC2-18AC-48BD-9E84-3A963AD43DBC

Q39296306-6F8C1A49-E015-48FD-8290-8CEA8588E891

P304

Q39296306-4F1EBF25-68D6-4A43-B87A-9DCAD86A0B11

P31

Q39296306-D822369D-9051-4372-B3F1-801B08DFBFCC

P356

Q39296306-122E25F6-44D6-4B41-B32C-C8121BD3F058

P407

Q39296306-8E19CEF9-8629-4E0A-BF95-D9883DC1957E

P433

Q39296306-F04BB2D9-D929-4607-B8E7-C8FEA847C8C9

P478

Q39296306-867A2818-966A-4450-804F-FD455CF83F01

P50

Q39296306-1C6A301D-2782-45A7-8A03-62ABA9912015

P577

Q39296306-7805B3FB-E9E3-4F91-B9D4-FC9F0A67D262

P5875

Q39296306-03DBEBD6-F6AF-476D-9F24-0BC3D75059B3

P698

Q39296306-8B148E6B-F2FD-4C43-AC33-A460D1C96C77

P356

P1433

The New England Journal of Medicine

P1476

Vaccination against HPV-16 oncoproteins for vulvar intraepithelial neoplasia.

@en

P2093

A Rob P M Valentijn

http://www.w3.org/2001/XMLSchema#string

Amon R Wafelman

http://www.w3.org/2001/XMLSchema#string

Annelies P G Vloon

http://www.w3.org/2001/XMLSchema#string

Cornelis J M Melief

http://www.w3.org/2001/XMLSchema#string

Dorien M A Berends-van der Meer

http://www.w3.org/2001/XMLSchema#string

Farah Essahsah

http://www.w3.org/2001/XMLSchema#string

Gert Jan Fleuren

http://www.w3.org/2001/XMLSchema#string

Jaap Oostendorp

http://www.w3.org/2001/XMLSchema#string

Jan Wouter Drijfhout

http://www.w3.org/2001/XMLSchema#string

Lorraine M Fathers

http://www.w3.org/2001/XMLSchema#string

P304

1838-1847

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJMOA0810097

http://www.w3.org/2001/XMLSchema#string

P407

P433

19

http://www.w3.org/2001/XMLSchema#string

P478

361

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

38067819

http://www.w3.org/2001/XMLSchema#string

P698

19890126

http://www.w3.org/2001/XMLSchema#string